{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T20:40:53Z","timestamp":1773002453433,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,7,20]],"date-time":"2007-07-20T00:00:00Z","timestamp":1184889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2007,9,10]]},"DOI":"10.1007\/s00213-007-0831-y","type":"journal-article","created":{"date-parts":[[2007,7,19]],"date-time":"2007-07-19T04:02:39Z","timestamp":1184817759000},"page":"423-432","source":"Crossref","is-referenced-by-count":24,"title":["Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats"],"prefix":"10.1007","volume":"194","author":[{"given":"Roselei","family":"Fachinetto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jardel G.","family":"Villarinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romaiana P.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robson L.","family":"Puntel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcio W.","family":"Paix\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio L.","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Batista","family":"Calixto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o B. T.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliano","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,7,20]]},"reference":[{"key":"831_CR1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuropharm.2004.04.003","volume":"47","author":"VC Ab\u00edlio","year":"2004","unstructured":"Ab\u00edlio VC, Silva RH, Carvalho RC, Grassl C, Calzavara MB, Registro S, D\u2019Almeida V, Ribeiro RA, Frussa-Filho R (2004) Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia. Neuropharmacology 47:263\u2013272","journal-title":"Neuropharmacology"},{"key":"831_CR2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archpsyc.56.9.836","volume":"56","author":"LA Adler","year":"1999","unstructured":"Adler LA, Rotrosen J, Edson R, Lavori P, Lohr J, Hitzemann R, Raisch D, Caliguri M, Tracy K (1999) Vitamin E treatment for tardive dyskinesia. Arch Gen Psychiatry 56:836\u2013841","journal-title":"Arch Gen Psychiatry"},{"key":"831_CR3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0301-0082(99)00064-7","volume":"61","author":"OA Andreassen","year":"2000","unstructured":"Andreassen OA, Jorgensen HA (2000) Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia? Prog Neurobiol 61:525\u2013541","journal-title":"Prog Neurobiol"},{"key":"831_CR4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.neuroscience.2003.08.058","volume":"122","author":"OA Andreassen","year":"2003","unstructured":"Andreassen OA, Ferrante RJ, Aamo TO, Beal MF, Jorgensen HA (2003) Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats. Neuroscience 122:717\u2013725","journal-title":"Neuroscience"},{"key":"831_CR5","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/0024-3205(96)00475-4","volume":"59","author":"KM Avent","year":"1996","unstructured":"Avent KM, Usuki E, Eyles DW, Keeve R, Van der Schyf CJ, Castagnoli N Jr, Pond SM (1996) Haloperidol and its tetrahydropyridine derivative (HPTP) are metabolized to potentially neurotoxic pyridinium species in the baboon. Life Sci 59:1473\u20131482","journal-title":"Life Sci"},{"key":"831_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2005.01.002","volume":"210","author":"LP Borges","year":"2005","unstructured":"Borges LP, Borges VC, Moro AV, Nogueira CW, Rocha JB, Zeni G (2005) Protective effect of diphenyl diselenide on acute liver damage induced by 2-nitropropane in rats. Toxicology 210:1\u20138","journal-title":"Toxicology"},{"key":"831_CR7","first-page":"987","volume":"244","author":"SJ Boyson","year":"1988","unstructured":"Boyson SJ, McGonigle P, Luthin GR, Wolfe BB, Molinoff PB (1988) Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum. J Pharmacol Exp Ther 244:987\u2013993","journal-title":"J Pharmacol Exp Ther"},{"key":"831_CR8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/01480540500262763","volume":"28","author":"R Brand\u00e3o","year":"2005","unstructured":"Brand\u00e3o R, Lara FS, Pagliosa LB, Soares FA, Rocha JB, Nogueira CW, Farina M (2005) Hemolytic effects of sodium selenite and mercuric chloride in human blood. Drug Chem Toxicol 28:397\u2013407","journal-title":"Drug Chem Toxicol"},{"key":"831_CR9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mam.2005.07.004","volume":"26","author":"P Brenneisen","year":"2005","unstructured":"Brenneisen P, Steinbrenner H, Sies H (2005) Selenium, oxidative stress, and health aspects. Mol Aspects Med 26:256\u2013267","journal-title":"Mol Aspects Med"},{"key":"831_CR10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0006-3223(97)00197-2","volume":"43","author":"K Brown","year":"1998","unstructured":"Brown K, Reid A, White T, Henderson T, Hukin S, Johnstone C, Glen A (1998) Vitamin E, lipids, and lipid peroxidation products in tardive dyskinesia. Biol Psychiatry 43:863\u2013867","journal-title":"Biol Psychiatry"},{"key":"831_CR11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.brainresbull.2004.09.006","volume":"64","author":"ME Burger","year":"2004","unstructured":"Burger ME, Fachinetto R, Calegari L, Paix\u00e3o MW, Braga AL, Rocha JBT (2004) Effects on age on orofacial dyskinesia reserpine-induced and possible protection of diphenyl-diselenide. Brain Res Bull 64:339\u2013345","journal-title":"Brain Res Bull"},{"key":"831_CR12","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.pbb.2005.05.002","volume":"81","author":"ME Burger","year":"2005a","unstructured":"Burger ME, Fachinetto R, Zeni G, Rocha JBT (2005a) Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain. Pharmacol Biochem Behav 81:608\u2013615","journal-title":"Pharmacol Biochem Behav"},{"key":"831_CR13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainres.2004.10.038","volume":"1031","author":"ME Burger","year":"2005b","unstructured":"Burger ME, Fachinetto R, Alves A, Calegari L, Rocha JBT (2005b) Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats. Brain Res 1031:202\u2013210","journal-title":"Brain Res"},{"key":"831_CR14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.brainresbull.2006.05.002","volume":"70","author":"MB Burger","year":"2006","unstructured":"Burger MB, Fachinetto R, Wagner C, Perottoni J, Pereira RP, Zeni G, Rocha JBT (2006) Effects of diphenyl-diselenide on orofacial dyskinesia model in rats. Brain Res Bull 70:165\u2013170","journal-title":"Brain Res Bull"},{"key":"831_CR15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1126\/science.847477","volume":"196","author":"D Burt","year":"1977","unstructured":"Burt D, Creese I, Snyder SH (1977) Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196:326\u2013327","journal-title":"Science"},{"key":"831_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0166-2236(86)90035-4","volume":"9","author":"JL Cadet","year":"1986","unstructured":"Cadet JL, Lohr JB, Jeste DV (1986) Free radical and tardive dyskinesia. Trends Neurosci 9:107\u2013108","journal-title":"Trends Neurosci"},{"key":"831_CR17","first-page":"425","volume-title":"Handbook of schizophrenia: the neurochemistry and pharmacology of schizophrenia","author":"JL Cadet","year":"1987","unstructured":"Cadet JL, Lohr JB, Jeste DV (1987) Tardive dyskinesia and Schizophrenic burnout: the possible involvement of cytotoxic free radicals. In: Henn FA, DeLisi LE (eds) Handbook of schizophrenia: the neurochemistry and pharmacology of schizophrenia. Elsevier, Amsterdam, pp 425\u2013438"},{"key":"831_CR18","first-page":"88","volume":"2","author":"DE Casey","year":"1985","unstructured":"Casey DE (1985) Tardive dyskinesia: reversible and irreversible. Psychopharmacology 2:88\u201397","journal-title":"Psychopharmacology"},{"key":"831_CR19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0232-1513(83)80052-8","volume":"23","author":"LW Chang","year":"1983","unstructured":"Chang LW (1983) Protective effects of selenium against methylmercury neurotoxicity: a morphological and biochemical study. Exp Pathol 23:143\u2013156","journal-title":"Exp Pathol"},{"key":"831_CR20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4615-0667-6_11","volume":"500","author":"JNM Commandeur","year":"2001","unstructured":"Commandeur JNM, Rooseboom M, Vermeulen NPE (2001) Chemistry and biological activity of novel selenium-containing compounds. Biological reactive intermediates VI. Adv Exp Med Biol 500:105","journal-title":"Adv Exp Med Biol"},{"key":"831_CR21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1192\/bjp.122.4.395","volume":"122","author":"GE Crane","year":"1973","unstructured":"Crane GE (1973) Persistent dyskinesia. Br J Psychiatry 122:395\u2013405","journal-title":"Br J Psychiatry"},{"key":"831_CR22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1176\/ajp.151.6.925","volume":"151","author":"LM Dabiri","year":"1994","unstructured":"Dabiri LM, Pasta D, Darby JK, Mosbacher D (1994) Effectiveness of vitamin E for treatment of long-term tardive dyskinesia. Am J Psychiatry 151:925\u2013926","journal-title":"Am J Psychiatry"},{"key":"831_CR23","first-page":"575","volume":"47","author":"M Ebadi","year":"1995","unstructured":"Ebadi M, Srinivasan SK (1995) Pathogenesis, prevention and treatment of neuroleptic-induced movement disorders. Pharmacol Rev 47:575\u2013604","journal-title":"Pharmacol Rev"},{"key":"831_CR24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1176\/ajp.149.6.773","volume":"149","author":"MF Egan","year":"1992","unstructured":"Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, Blum A, Saenz RE, Wyatt RJ (1992) Treatment of tardive dyskinesia with vitamin E. Am J Psychiatry 149:773\u2013777","journal-title":"Am J Psychiatry"},{"key":"831_CR25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/syn.890180303","volume":"18","author":"MF Egan","year":"1994","unstructured":"Egan MF, Hurd Y, Hyde TM, Weinberger DR, Wyatt RJ, Kleinman JE (1994) Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias. Synapse 18:178\u2013189","journal-title":"Synapse"},{"key":"831_CR26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s002130050095","volume":"127","author":"MF Egan","year":"1996","unstructured":"Egan MF, Hurd Y, Ferguson J, Bachus SE, Hamid EH, Hyde TM (1996) Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol. Psychopharmacology 127:337\u2013345","journal-title":"Psychopharmacology"},{"key":"831_CR27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.pbb.2005.05.001","volume":"81","author":"R Fachinetto","year":"2005","unstructured":"Fachinetto R, Burger MB, Wagner C, Wondracek DC, Brito VB, Nogueira CW, Ferreira J, Rocha JBT (2005) High fat diet increases the incidence of orofacial dyskinesia and oxidative stress in specific brain regions of rats. Pharmacol Biochem Behav 81:585\u2013592","journal-title":"Pharmacol Biochem Behav"},{"key":"831_CR28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.neuropharm.2005.01.014","volume":"48","author":"RR Faria","year":"2005","unstructured":"Faria RR, Abilio VC, Grassl C, Chinen CC, Negrao LT, de Castro JP, Fukushiro DF, Rodrigues MS, Gomes PH, Registro S, de Carvalho RC, D\u2019Almeida V, Silva RH, Ribeiro RA, Frussa-Filho R (2005) Beneficial effects of vitamin C and vitamin E on reserpine-induced oral dyskinesia in rats: critical role of striatal catalase activity. Neuropharmacology 48:993\u20131001","journal-title":"Neuropharmacology"},{"key":"831_CR29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1600-0447.1988.tb05138.x","volume":"77","author":"J Gerlach","year":"1988","unstructured":"Gerlach J, Casey D (1988) Tardive dyskinesia. Acta Psychiatr Scand 77:369\u2013378","journal-title":"Acta Psychiatr Scand"},{"key":"831_CR30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/309347a0","volume":"309","author":"L Gunne","year":"1984","unstructured":"Gunne L, H\u00e4ggstr\u00f6m J, Sj\u00f6quist B (1984) Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature 309:347\u2013349","journal-title":"Nature"},{"key":"831_CR31","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1038\/sj.npp.1300512","volume":"29","author":"K Hashimoto","year":"2004","unstructured":"Hashimoto K, Tsukada H, Nishiyama S, Fukumoto D, Kakiuchi T, Shimizu E, Iyo M (2004) Protective effects of N-acetyl-L-cysteine on the reduction of dopamine transporters in the striatum of monkeys treated with methamphetamine. Neuropsychopharmacology 29:2018\u20132023","journal-title":"Neuropsychopharmacology"},{"key":"831_CR32","first-page":"746","volume":"10","author":"RW Holz","year":"1974","unstructured":"Holz RW, Coyle JT (1974) The effects of various salts, temperature and the alkaloids veratridine and batrachotoxin on the uptake of 3H-dopamine into synaptosomes from rat striatum. Mol Pharmacol 10:746\u2013758","journal-title":"Mol Pharmacol"},{"key":"831_CR33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0301-0082(90)90033-D","volume":"34","author":"AS Horn","year":"1990","unstructured":"Horn AS (1990) Dopamine uptake: a review of progress in the last decade. Prog Neurobiol 34:387\u2013400","journal-title":"Prog Neurobiol"},{"key":"831_CR34","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1046\/j.1471-4159.2003.01936.x","volume":"86","author":"CL Huang","year":"2003","unstructured":"Huang CL, Huang NK, Shyue SK, Chern Y (2003) Hydrogen peroxide induces loss of dopamine transporter activity: a calcium-dependent oxidative mechanism. J Neurochem 86:1247\u20131259","journal-title":"J Neurochem"},{"key":"831_CR35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1476-5381.1971.tb07066.x","volume":"41","author":"LL Iversen","year":"1971","unstructured":"Iversen LL (1971) Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 41:571\u2013591","journal-title":"Br J Pharmacol"},{"key":"831_CR36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0361-9230(91)90235-C","volume":"26","author":"V Jackson-Lewis","year":"1991","unstructured":"Jackson-Lewis V, Przedborski S, Kostic V, Suber F, Fahn S, Cadet JL (1991) Partial attenuation of chronic fluphenazine-induced changes in regional monoamine metabolism by D-alpha-tocopherol in rat brain. Brain Res Bull 26:251\u2013258","journal-title":"Brain Res Bull"},{"key":"831_CR37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0006-2952(94)00424-K","volume":"49","author":"I Jeding","year":"1995","unstructured":"Jeding I, Evans PJ, Akanmu D, Dexter D, Spencer JD, Aruoma OI, Jenner P, Halliwell B (1995) Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs. Biochem Pharmacol 49:359\u2013365","journal-title":"Biochem Pharmacol"},{"key":"831_CR38","first-page":"223","volume-title":"Neuroleptics: neurochemical, behavioral and, clinical perspectives","author":"P Jenner","year":"1983","unstructured":"Jenner P, Marsden CD (1983) Neuroleptics and tardive dyskinesia. In: Coyle JT, Enna SJ (eds) Neuroleptics: neurochemical, behavioral and, clinical perspectives. Raven Press, New York, pp 223\u2013253"},{"key":"831_CR39","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archpsyc.1979.01780050095012","volume":"36","author":"DV Jeste","year":"1979","unstructured":"Jeste DV, Potkin SG, Sinh\u00e1 S, Feder S, Wyatt RJ (1979) Tardive dyskinesia\u2014reversible and persistent. Arch Gen Psychiatry 36:585\u2013590","journal-title":"Arch Gen Psychiatry"},{"key":"831_CR40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/BF02801966","volume":"106","author":"DV Jeste","year":"1992","unstructured":"Jeste DV, Lohr JB, Manley M (1992) Study of neuropathologic changes in the striatum following 4, 8 and 12\u00a0months of treatment with fluphenazine in rats. Psychopharmacology 106:154\u2013160","journal-title":"Psychopharmacology"},{"key":"831_CR41","first-page":"1485","volume-title":"Psychopharmacology: the fourth generation of progress","author":"JM Kane","year":"1995","unstructured":"Kane JM (1995) Tardive dyskinesia: epidemiology and clinical presentation. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress, vol. 39. Raven Press, New York 1485\u20131495"},{"key":"831_CR42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archpsyc.1982.04290040069010","volume":"39","author":"JM Kane","year":"1982","unstructured":"Kane JM, Smith JM (1982) Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry 39:473\u2013481","journal-title":"Arch Gen Psychiatry"},{"key":"831_CR43","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/jn\/133.5.1448S","volume":"133","author":"LO Klotz","year":"2003","unstructured":"Klotz LO, Kroncke KD, Buchczyk DP, Sies H (2003) Role of copper, zinc, selenium and tellurium in the cellular defense against oxidative and nitrosative stress. J Nutr 133:1448","journal-title":"J Nutr"},{"key":"831_CR44","first-page":"446","volume":"35","author":"S Lee","year":"1997","unstructured":"Lee S, Oh D, Jung S, Kim Y, Cho H, Koh J, Lee Y (1997) Neuroleptic drugs alter the dopamine transporter-mediated uptake and release of dopamine: a possible mechanism for drug-induced tardive dyskinesia. Pharmacol Res 35:446\u2013450","journal-title":"Pharmacol Res"},{"key":"831_CR45","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(87)92878-9","volume":"1","author":"JB Lohr","year":"1987","unstructured":"Lohr JB, Cadet JL, Lohr MA, Jeste DV, Wyatt RJ (1987) Alpha-tocopherol in tardive dyskinesia. Lancet 1:913\u2013934","journal-title":"Lancet"},{"key":"831_CR46","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0006-3223(90)90490-S","volume":"28","author":"JB Lohr","year":"1990","unstructured":"Lohr JB, Kuczenski R, Bracha HS, Moir M, Jeste DV (1990) Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol Psychiatry 28:535\u2013539","journal-title":"Biol Psychiatry"},{"key":"831_CR47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002130050039","volume":"148","author":"JB Lohr","year":"2000","unstructured":"Lohr JB, Caligiuri MP, Manley MS, Browning JA (2000) Neuroleptic-induced striatal damage in rats: a study of antioxidant treatment using accelerometric and immunocytochemical methods. Psychopharmacology 148:171\u2013179","journal-title":"Psychopharmacology"},{"key":"831_CR48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00023210-200317010-00004","volume":"17","author":"JB Lohr","year":"2003","unstructured":"Lohr JB, Kuczenski R, Niculescu AB (2003) Oxidative mechanisms and tardive dyskinesia. CNS Drugs 17:47\u201362","journal-title":"CNS Drugs"},{"key":"831_CR49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265","journal-title":"J Biol Chem"},{"key":"831_CR50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF03033354","volume":"10","author":"C Mehler-Wex","year":"2006","unstructured":"Mehler-Wex C, Riederer P, Gerlach M (2006) Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson\u2019s disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox Res 10:167\u2013179","journal-title":"Neurotox Res"},{"key":"831_CR51","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00213-002-1139-6","volume":"163","author":"KA Miczek","year":"2002","unstructured":"Miczek KA, Fish EW, De Bold JF, De Almeida RM (2002) Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems. Psychopharmacology 163:434\u2013458","journal-title":"Psychopharmacology"},{"key":"831_CR52","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/S0021-9258(19)45228-9","volume":"247","author":"HP Misra","year":"1972","unstructured":"Misra HP, Fridovich I (1972) The role of superoxide anion in the autoxidation of epinephrine and simple assay for superoxide dismutase. J Biol Chem 247:3170\u20133175","journal-title":"J Biol Chem"},{"key":"831_CR53","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0028-3908(03)00101-1","volume":"44","author":"PS Naidu","year":"2003","unstructured":"Naidu PS, Singh A, Kaur P, Kulkarni SK (2003) Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia. Neuropharmacology 44:1100\u20131106","journal-title":"Neuropharmacology"},{"key":"831_CR54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-8993(01)02165-5","volume":"906","author":"CW Nogueira","year":"2001","unstructured":"Nogueira CW, Rotta LN, Perry ML, Souza DO, Rocha JBT (2001) Diphenyl diselenide and diphenyl ditelluride affect the rat glutamatergic system in vitro and in vivo. Brain Res 906:157\u2013163","journal-title":"Brain Res"},{"key":"831_CR55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0300-483X(02)00423-7","volume":"183","author":"CW Nogueira","year":"2003","unstructured":"Nogueira CW, Meotti FC, Curte E, Piliss\u00e3o C, Zeni G, Rocha JBT (2003) Investigations into the potencial neurotoxicity induced by diselenides in mice and rats. Toxicology 183:29\u201337","journal-title":"Toxicology"},{"key":"831_CR56","doi-asserted-by":"crossref","first-page":"6255","DOI":"10.1021\/cr0406559","volume":"104","author":"CW Nogueira","year":"2004","unstructured":"Nogueira CW, Zeni G, Rocha JBT (2004) Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem Rev 104:6255\u20136286","journal-title":"Chem Rev"},{"key":"831_CR57","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi H, Yagi K (1979) Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351\u2013358","journal-title":"Anal Biochem"},{"key":"831_CR58","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0140-6736(87)92987-4","volume":"2","author":"HS Pall","year":"1987","unstructured":"Pall HS, Williams AC, Blake DR, Lunee J (1987) Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines. Lancet 2:596\u2013599","journal-title":"Lancet"},{"key":"831_CR59","unstructured":"Palmier C (1986) Selenium reagents and intermediates. In: Organic synthesis. Pergamon, Oxford"},{"key":"831_CR60","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.neuint.2004.06.008","volume":"45","author":"P P\u00e9rez-Severiano","year":"2004","unstructured":"P\u00e9rez-Severiano P, Rodr\u00edguez-P\u00e9rez M, Pedraza-Chaverr\u00ed J, Maldonado PD, Medina-Campos ON, Ort\u00edz-Plata A, S\u00e1nchez-Garc\u00eda A, Villeda-Hern\u00e1ndez J, Galv\u00e1n-Arzate S, Aguilera P, Santamar\u00eda A (2004) S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats. Neurochem Int 45:1175\u20131183","journal-title":"Neurochem Int"},{"key":"831_CR61","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0893-133X(01)00364-5","volume":"26","author":"A Post","year":"2002","unstructured":"Post A, Rucker M, Ohl F, Uhr M, Holsboer F, Almeida OFX, Michaelidis TM (2002) Mechanisms underlying the protective potential of alpha-tocopherol (vitamin E) against haloperidol-associated neurotoxicity. Neuropsychopharmacology 26:397\u2013407","journal-title":"Neuropsychopharmacology"},{"key":"831_CR62","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0006-3223(99)00091-8","volume":"46","author":"P Sachdev","year":"1999","unstructured":"Sachdev P, Saharov T, Cathcart S (1999) The preventative role of antioxidants (selegiline and vitamin E) in a rat model of tardive dyskinesia. Biol Psychiatry 46:1672\u20131681","journal-title":"Biol Psychiatry"},{"key":"831_CR63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.wnf.0000191331.54649.e3","volume":"28","author":"O Sadan","year":"2005","unstructured":"Sadan O, Bahat-Stromza M, Gilgun-Sherki Y, Atlas D, Melamed E, Offen D (2005) A novel brain-targeted antioxidant (AD4) attenuates haloperidol-induced abnormal movement in rats: implications for tardive dyskinesia. Clin Neuropharmacol 28:285\u2013288","journal-title":"Clin Neuropharmacol"},{"key":"831_CR64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cbi.2005.01.001","volume":"151","author":"FW Santos","year":"2005","unstructured":"Santos FW, Zeni G, Rocha JB, Weis SN, Fachinetto JM, Favero AM, Nogueira CW (2005) Diphenyl diselenide reverses cadmium-induced oxidative damage on mice tissues. Chem Biol Interact 151:159\u2013165","journal-title":"Chem Biol Interact"},{"key":"831_CR65","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/npp.1993.48","volume":"9","author":"RE See","year":"1993","unstructured":"See RE (1993) Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia. Neuropsychopharmacology 9:101\u2013109","journal-title":"Neuropsychopharmacology"},{"key":"831_CR66","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/exnr.1994.1080","volume":"127","author":"O Shirakawa","year":"1994","unstructured":"Shirakawa O, Tamminga CA (1994) Basal ganglia GABAA and dopamine D1 binding site correlates of haloperidol-induced oral dyskinesias in rat. Exp Neurol 127:62\u201369","journal-title":"Exp Neurol"},{"key":"831_CR67","first-page":"1137","volume":"265","author":"BR Shivakumar","year":"1993","unstructured":"Shivakumar BR, Ravindratnath V (1993) Oxidative stress and thiol modification induced by chronic administration of haloperidol. J Pharmacol Exp Ther 265:1137\u20131141","journal-title":"J Pharmacol Exp Ther"},{"key":"831_CR68","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.freeradbiomed.2005.12.022","volume":"40","author":"H Steinbrenner","year":"2006","unstructured":"Steinbrenner H, Alili L, Bilgic E, Sies H, Brenneisen P (2006) Involvement of selenoprotein P in protection of human astrocytes from oxidative damage. Free Radic Biol Med 40:1513\u20131523","journal-title":"Free Radic Biol Med"},{"key":"831_CR69","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1176\/ajp.155.9.1207","volume":"155","author":"G Tsai","year":"1998","unstructured":"Tsai G, Goff DC, Chang RW, Flood J, Baer L, Coyle JT (1998) Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am J Psychiatry 155:1207\u20131213","journal-title":"Am J Psychiatry"},{"key":"831_CR70","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00213-006-0637-3","volume":"191","author":"AM Erp van","year":"2007","unstructured":"van Erp AM, Miczek KA (2007) Increased accumbal dopamine during daily alcohol consumption and subsequent aggressive behavior in rats. Psychopharmacology 191:679\u2013688","journal-title":"Psychopharmacology"},{"key":"831_CR71","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0306-4522(00)00412-7","volume":"101","author":"JM Kampen Van","year":"2000","unstructured":"Van Kampen JM, Stoessl AJ (2000) Dopamine D1A receptor function in a rodent model of tardive dyskinesia. Neuroscience 101:629\u2013635","journal-title":"Neuroscience"},{"key":"831_CR72","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00517390","volume":"292","author":"TC Westfall","year":"1976","unstructured":"Westfall TC, Besson M, Giorguieff M, Glowinski J (1976) The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum. Arch Pharmacol 292:279\u2013287","journal-title":"Arch Pharmacol"},{"key":"831_CR73","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00004714-199102000-00005","volume":"11","author":"MG Woerner","year":"1991","unstructured":"Woerner MG, Kane JM, Lieberman JA, Alvir J, Bergmann KJ, Borenstein M, Schooler NR, Mukherjee S, Rotrosen J, Rubinstein M et al (1991) The prevalence of tardive dyskinesia. J Clin Psychopharmacol 11:34\u201342","journal-title":"J Clin Psychopharmacol"},{"key":"831_CR74","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0006-8993(97)01551-5","volume":"788","author":"AM Wright","year":"1998","unstructured":"Wright AM, Bempong J, Kirby ML, Barlow RL, Bloomquist JR (1998) Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia. Brain Res 788:215\u2013222","journal-title":"Brain Res"},{"key":"831_CR75","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1471-4159.2003.01531.x","volume":"84","author":"KS Zafar","year":"2003","unstructured":"Zafar KS, Siddiqui A, Sayeed I, Ahmad M, Salim S, Islam F (2003) Dose-dependent protective effect of selenium in rat model of Parkinson\u2019s disease: neurobehavioral and neurochemical evidences. J Neurochem 84:438\u2013446","journal-title":"J Neurochem"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0831-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-007-0831-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-007-0831-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T23:39:35Z","timestamp":1629416375000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-007-0831-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,20]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9,10]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1007\/s00213-007-0831-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,20]]}}}